GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » EV-to-EBITDA

HLB Panagene Co (XKRX:046210) EV-to-EBITDA : -12.76 (As of Sep. 21, 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, HLB Panagene Co's enterprise value is ₩98,528 Mil. HLB Panagene Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-7,720 Mil. Therefore, HLB Panagene Co's EV-to-EBITDA for today is -12.76.

The historical rank and industry rank for HLB Panagene Co's EV-to-EBITDA or its related term are showing as below:

XKRX:046210' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2484.57   Med: 15   Max: 732.94
Current: -12.77

During the past 13 years, the highest EV-to-EBITDA of HLB Panagene Co was 732.94. The lowest was -2484.57. And the median was 15.00.

XKRX:046210's EV-to-EBITDA is ranked worse than
100% of 459 companies
in the Biotechnology industry
Industry Median: 8.73 vs XKRX:046210: -12.77

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-21), HLB Panagene Co's stock price is ₩3430.00. HLB Panagene Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩-224.000. Therefore, HLB Panagene Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


HLB Panagene Co EV-to-EBITDA Historical Data

The historical data trend for HLB Panagene Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co EV-to-EBITDA Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.31 20.26 16.57 33.65 -29.31

HLB Panagene Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.20 80.43 -29.31 -34.86 -9.91

Competitive Comparison of HLB Panagene Co's EV-to-EBITDA

For the Biotechnology subindustry, HLB Panagene Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's EV-to-EBITDA falls into.



HLB Panagene Co EV-to-EBITDA Calculation

HLB Panagene Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=98528.431/-7719.884
=-12.76

HLB Panagene Co's current Enterprise Value is ₩98,528 Mil.
HLB Panagene Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,720 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Panagene Co  (XKRX:046210) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HLB Panagene Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3430.00/-224.000
=At Loss

HLB Panagene Co's share price for today is ₩3430.00.
HLB Panagene Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-224.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


HLB Panagene Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co Headlines

No Headlines